Current status on electrodiagnostic standards and guidelines in neuromuscular disorders

Clinical Neurophysiology

Volumn 122, Issue 3, 2011, Pages 440-455

  Fuglsang Frederiksen, Anders ^a   Pugdahl, Kirsten ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Electrodiagnostic medicine; EMG; Guidelines; Medical technology assessment; Neuromuscular disorders; Standards

Indexed keywords

ACUTE INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY; AMYOTROPHIC LATERAL SCLEROSIS; AXONAL POLYNEUROPATHY; BIOMEDICAL TECHNOLOGY ASSESSMENT; CARPAL TUNNEL SYNDROME; CERVICOBRACHIAL NEURALGIA; CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY; DEMYELINATING DISEASE; DISTAL SYMMETRIC POLYNEUROPATHY; ELECTRODIAGNOSIS; EVIDENCE BASED MEDICINE; HEREDITARY POLYNEUROPATHY; HUMAN; MEDICAL AUDIT; MEDICAL LITERATURE; MEDICAL RESEARCH; MIXED POLYNEUROPATHY; MOTOR NERVE CONDUCTION; MULTIFOCAL MOTOR NEUROPATHY; NERVE FIBER; NERVOUS SYSTEM INFLAMMATION; NEUROMUSCULAR DISEASE; NEUROPATHY; NEUROPHYSIOLOGY; PATHOPHYSIOLOGY; PERONEAL NEUROPATHY; POLYNEUROPATHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; REVIEW; SENSORY NERVE CONDUCTION; TARSAL TUNNEL SYNDROME; ULNAR NERVE;

ELECTRODIAGNOSIS; EVIDENCE-BASED MEDICINE; GUIDELINES AS TOPIC; HUMANS; NEUROMUSCULAR DISEASES; QUALITY CONTROL; QUALITY IMPROVEMENT; TECHNOLOGY ASSESSMENT, BIOMEDICAL; TECHNOLOGY, MEDICAL; TREATMENT OUTCOME;

EID: 78751627332     PISSN: 13882457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinph.2010.06.025     Document Type: Review

References (139)

1. AAEM. Practice parameter for electrodiagnostic studies in carpal tunnel syndrome: summary statement. American Association of Electrodiagnostic Medicine, American Academy of Neurology, American Academy of Physical Medicine and Rehabilitation. Muscle Nerve 1993;16:1390-1.
2. AAEM. Guidelines in electrodiagnostic medicine. Practice parameter for electrodiagnostic studies in carpal tunnel syndrome. Muscle Nerve Suppl 1999;8:S141-67.
3. AAEM. Guidelines in electrodiagnostic medicine. Practice parameter for needle electromyographic evaluation of patients with suspected cervical radiculopathy. Muscle Nerve Suppl 1999;8:S209-21.
4. AAEM, American Academy of Neurology, American Academy of Physical Medicine and Rehabilitation. Practice parameter for electrodiagnostic studies in carpal tunnel syndrome: summary statement. Muscle Nerve 2002;25:918-22.
5. AAEM, Campbell W.W. Guidelines in electrodiagnostic medicine. Practice parameter for electrodiagnostic studies in ulnar neuropathy at the elbow. Muscle Nerve 1999, 8:S171-S205.
6. AAEM Quality Assurance Committee Practice parameter for repetitive nerve stimulation and single fiber EMG evaluation of adults with suspected myasthenia gravis or Lambert-Eaton myasthenic syndrome: summary statement. Muscle Nerve 2001, 24:1236-1238.
7. AAN Ad hoc subcommittee. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Neurology 1991;41:617-8.
8. Albers J.W. Clinical neurophysiology of generalized polyneuropathy. J Clin Neurophysiol 1993, 10:149-166.
9. Albers J.W., Donofrio P.D., McGonagle T.K. Sequential electrodiagnostic abnormalities in acute inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 1985, 8:528-539.
10. Albers J.W., Kelly J.J. Acquired inflammatory demyelinating polyneuropathies: clinical and electrodiagnostic features. Muscle Nerve 1989, 12:435-451.
11. American Association of Electrodiagnostic Medicine Guidelines in electrodiagnostic medicine. Muscle Nerve 1992, 15:229-253.
12. Andersson P.B., Yuen E., Parko K., So Y.T. Electrodiagnostic features of hereditary neuropathy with liability to pressure palsies. Neurology 2000, 54:40-44.
13. Asbury A.K., Cornblath D.R. Assessment of current diagnostic criteria for Guillain-Barre syndrome. Ann Neurol 1990, 27(Suppl.):S21-S24.
14. Barohn R.J., Kissel J.T., Warmolts J.R., Mendell J.R. Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria. Arch Neurol 1989, 46:878-884.
15. Beghi E., Balzarini C., Bogliun G., Logroscino G., Manfredi L., Mazzini L., et al. Reliability of the El Escorial diagnostic criteria for amyotrophic lateral sclerosis. Neuroepidemiology 2002, 21:265-270.
16. Behnia M., Kelly J.J. Role of electromyography in amyotrophic lateral sclerosis. Muscle Nerve 1991, 14:1236-1241.
17. Behse F., Buchthal F. Peroneal muscular atrophy (PMA) and related disorders. II. Histological findings in sural nerves. Brain 1977, 100(Pt 1):67-85.
18. Beyer M., Gerlach F.M., Flies U., Grol R., Krol Z., Munck A., et al. The development of quality circles/peer review groups as a method of quality improvement in Europe. Results of a survey in 26 European countries. Fam Pract 2003, 20:443-451.
19. Birouk N., LeGuern E., Maisonobe T., Rouger H., Gouider R., Tardieu S., et al. X-linked Charcot-Marie-Tooth disease with connexin 32 mutations: clinical and electrophysiologic study. Neurology 1998, 50:1074-1082.
20. Bischoff C., Fuglsang-Fredriksen A., Vendelbo L., Sumner A. Standards of instrumentation of EMG. The International Federation of Clinical Neurophysiology. Electroencephalogr Clin Neurophysiol Suppl 1999, 52:199-211.
21. Bossuyt P.M., Reitsma J.B., Bruns D.E., Gatsonis C.A., Glasziou P.P., Irwig L.M., et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Clin Chem 2003, 49:7-18.
22. Bouche P., Gherardi R., Cathala H.P., Lhermitte F., Castaigne P. Peroneal muscular atrophy. Part 1. Clinical and electrophysiological study. J Neurol Sci 1983, 61:389-399.
23. Boukhris S., Magy L., Kabore R., Mabrouk T., Li Y., Sindou P., et al. Atypical electrophysiologic findings in chronic inflammatory demyelinating polyneuropathy (CIDP) - diagnosis confirmed by nerve biopsy. Neurophysiol Clin 2004, 34:71-79.
24. Bragg J.A., Benatar M.G. Sensory nerve conduction slowing is a specific marker for CIDP. Muscle Nerve 2008, 38:1599-1603. [ref type: case].
25. Bril V., Ellison R., Ngo M., Bergstrom B., Raynard D., Gin H. Electrophysiological monitoring in clinical trials. Roche Neuropathy Study Group. Muscle Nerve 1998, 21:1368-1373.
26. Bromberg M.B. Comparison of electrodiagnostic criteria for primary demyelination in chronic polyneuropathy. Muscle Nerve 1991, 14:968-976.
27. Brooks B.R. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors. J Neurol Sci 1994, 124(Suppl.):96-107.
28. Brooks B.R., Miller R.G., Swash M., Munsat T.L. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000, 1:293-299.
29. Buchthal F. Electromyography in the Evaluation of Muscle Diseases. Methods Clin Neurophysiol 1991, 2:25-45.
30. Buchthal F., Behse F. Peroneal muscular atrophy (PMA) and related disorders. I. Clinical manifestations as related to biopsy findings, nerve conduction and electromyography. Brain 1977, 100(Pt 1):41-66.
31. Campbell W.W., Robinson L.R. Deriving reference values in electrodiagnostic medicine. Muscle Nerve 1993, 16:424-428.
32. Chaudhry V., Cornblath D.R., Mellits E.D., Avila O., Freimer M.L., Glass J.D., et al. Inter- and intra-examiner reliability of nerve conduction measurements in normal subjects. Ann Neurol 1991, 30:841-843.
33. Chaudhry V., Corse A.M., Freimer M.L., Glass J.D., Mellits E.D., Kuncl R.W., et al. Inter- and intraexaminer reliability of nerve conduction measurements in patients with diabetic neuropathy. Neurology 1994, 44:1459-1462.
34. Chaudhuri K.R., Crump S., al Sarraj S., Anderson V., Cavanagh J., Leigh P.N. The validation of El Escorial criteria for the diagnosis of amyotrophic lateral sclerosis: a clinicopathological study. J Neurol Sci 1995, 129(Suppl.):11-12.
35. Cho S.C., Siao-Tick-Chong P., So Y.T. Clinical utility of electrodiagnostic consultation in suspected polyneuropathy. Muscle Nerve 2004, 30:659-662.
36. Cleland J.C., Logigian E.L., Thaisetthawatkul P., Herrmann D.N. Dispersion of the distal compound muscle action potential in chronic inflammatory demyelinating polyneuropathy and carpal tunnel syndrome. Muscle Nerve 2003, 28:189-193.
37. Cleland J.C., Malik K., Thaisetthawatkul P., Herrmann D.N., Logigian E.L. Acute inflammatory demyelinating polyneuropathy: contribution of a dispersed distal compound muscle action potential to electrodiagnosis. Muscle Nerve 2006, 33:771-777.
38. Cocito D., Tavella A., Ciaramitaro P., Costa P., Poglio F., Paolasso I., et al. A further critical evaluation of requests for electrodiagnostic examinations. Neurol Sci 2006, 26:419-422.
39. Cohen M.M., Rose D.K., Yee D.A. Changing anesthesiologists' practice patterns. Can it be done?. Anesthesiology 1996, 85:260-269.
40. Combarros O., Calleja J., Figols J., Cabello A., Berciano J. Dominantly inherited motor, sensory neuropathy type I. Genetic, clinical, electrophysiological and pathological features in four families. J Neurol Sci 1983, 61:181-191.
41. Daube JR, Rubin DI. Electrodiagnosis of muscle disorders. In: Engel AG, Franzini-Armstrong C, editors. Myology; 2004. p. 619-54.
42. de Carvalho M., Dengler R., Eisen A., England J.D., Kaji R., Kimura J., et al. Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol 2008, 497-503.
43. Donofrio P.D., Albers J.W. AAEM minimonograph #34: polyneuropathy: classification by nerve conduction studies and electromyography. Muscle Nerve 1990, 13:889-903.
44. Dubinsky R.M., Werner R.A., Haig A.J., Miller R.G. Will EDX physicians be left behind? The need for blinded studies to evaluate electrodiagnostic studies as a diagnostic test. Positive Waves 2003, 11(Suppl.):1-4.
45. Dyck P.J., Johnson W.J., Lambert E.H., O'Brien P.C. Segmental demyelination secondary to axonal degeneration in uremic neuropathy. Mayo Clin Proc 1971, 46:400-431.
46. Dyck P.J., Lais A.C., Ohta M., Bastron J.A., Okazaki H., Groover R.V. Chronic inflammatory polyradiculoneuropathy. Mayo Clin Proc 1975, 50:621-637.
47. Dyck P.J., O'Brien P.C., Litchy W.J., Harper C.M., Daube J.R., Dyck P.J. Use of percentiles and normal deviates to express nerve conduction and other test abnormalities. Muscle Nerve 2001, 24:307-310.
48. EFNS-PNS Task Force. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - First Revision. Eur J Neurol 2010;17:356-63.
49. EFNS-PNS Task Force. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. J Peripher Nerv Syst 2005;10:220-8.
50. England J.D., Gronseth G.S., Franklin G., Carter G.T., Kinsella L.J., Cohen J.A., et al. Evaluation of distal symmetric polyneuropathy: the role of laboratory and genetic testing (an evidence-based review). Muscle Nerve 2009, 39:116-125.
51. England J.D., Gronseth G.S., Franklin G., Miller R.G., Asbury A.K., Carter G.T., et al. Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 2005, 64:199-207.
52. Falck B., Stalberg E. Motor nerve conduction studies: measurement principles and interpretation of findings. J Clin Neurophysiol 1995, 12:254-279.
53. Falck B., Stalberg E., Bischoff C. Sensory nerve conduction studies with surface electrodes. Methods Clin Neurophysiol 1994, 5:1-20.
54. Feasby T.E., Brown W.F., Gilbert J.J., Hahn A.F. The pathological basis of conduction block in human neuropathies. J Neurol Neurosurg Psychiatry 1985, 48:239-244.
55. Finnerup N.B., Johnsen B., Fuglsang-Frederiksen A., de Carvalho M., Fawcett P., Liguori R., et al. Can medical audit change electromyographic practice?. Electroencephalogr Clin Neurophysiol 1998, 109:496-501.
56. French CIDP Study Group Recommendations on diagnostic strategies for chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol Neurosurg Psychiatry 2008, 79:115-118.
57. Fuglsang-Frederiksen A. The role of different EMG methods in evaluating myopathy. Clin Neurophysiol 2006, 117:1173-1189.
58. Fuglsang-Frederiksen A. Diagnostic criteria for amyotrophic lateral sclerosis (ALS). Clin Neurophysiol 2008, 119:495-496.
59. Fuglsang-Frederiksen A., Johnsen B., de Carvalho M., Fawcett P.R., Liguori R., Nix W., et al. Variation in diagnostic strategy of the EMG examination - a multicentre study. Clin Neurophysiol 1999, 110:1814-1824.
60. Fuglsang-Frederiksen A., Johnsen B., Vingtoft S., Carvalho M., Fawcett P., Liguori R., et al. Variation in performance of the EMG examination at six European laboratories. Electroencephalogr Clin Neurophysiol 1995, 97:444-450.
61. Fuglsang-Frederiksen A., Rønager J., Vingtoft S. PC-KANDID: an expert system for electromyography. Artif Intell Med 1989, 1:117-124.
62. Gilliatt R.W. Nerve conduction in human and experimentalneuropathies. Proc Royal Soc Med 1966, 59:989-993.
63. Gutierrez A., England J.D., Sumner A.J., Ferer S., Warner L.E., Lupski J.R., et al. Unusual electrophysiological findings in X-linked dominant Charcot-Marie-Tooth disease. Muscle Nerve 2000, 23:182-188.
64. Hadden R.D., Cornblath D.R., Hughes R.A., Zielasek J., Hartung H.P., Toyka K.V., et al. Electrophysiological classification of Guillain-Barre syndrome: clinical associations and outcome. Plasma exchange/sandoglobulin Guillain-Barre syndrome Trial Group. Ann Neurol 1998, 44:780-788.
65. Haig A.J., Tzeng H.M., LeBreck D.B. The value of electrodiagnostic consultation for patients with upper extremity nerve complaints: a prospective comparison with the history and physical examination. Arch Phys Med Rehabil 1999, 80:1273-1281.
66. Hammad M., Silva A., Glass J., Sladky J.T., Benatar M. Clinical, electrophysiologic, and pathologic evidence for sensory abnormalities in ALS. Neurology 2007, 69:2236-2242.
67. Harding A.E., Thomas P.K. The clinical features of hereditary motor and sensory neuropathy types I and II. Brain 1980, 103:259-280.
68. Ho T.W., Li C.Y., Cornblath D.R., Gao C.Y., Asbury A.K., Griffin J.W., et al. Patterns of recovery in the Guillain-Barre syndromes. Neurology 1997, 48:695-700.
69. Ho T.W., Mishu B., Li C.Y., Gao C.Y., Cornblath D.R., Griffin J.W., et al. Guillain-Barre syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 1995, 118(Pt 3):597-605.
70. Hughes R., Bensa S., Willison H., Van den B.P., Comi G., Illa I., et al. Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 2001, 50:195-201.
71. Hughes R.A. Peripheral neuropathy. BMJ 2002, 324:466-469.
72. Isose S., Kuwabara S., Kokubun N., Sato Y., Mori M., Shibuya K., et al. The Tokyo Metropolitan Neuromuscular Electrodiagnosis Study Group. Utility of the distal compound muscle action potential duration for diagnosis of demyelinating neuropathies. J Peripher Nerv Syst 2009, 14:151-158.
73. Jablecki C.K., Andary M.T., Floeter M.K., Miller R.G., Quartly C.A., Vennix M.J., et al. Practice parameter: electrodiagnostic studies in carpal tunnel syndrome. Report of the American Association of Electrodiagnostic Medicine, American Academy of Neurology, and the American Academy of Physical Medicine and Rehabilitation. Neurology 2002, 58:1589-1592.
74. Jabre J.F., Sato L. The expression of electrophysiological data as mean related values. Muscle Nerve 1990, 13:861-862.
75. James B.C., Hammond M.E. The challenge of variation in medical practice. Arch Pathol Lab Med 2000, 124:1001-1003.
76. Johnsen B., Fuglsang-Frederiksen A. Electrodiagnosis of polyneuropathy. Neurophysiol Clin 2000, 30:339-351.
77. Johnsen B., Fuglsang-Frederiksen A., de Carvalho M., Labarre-Vila A., Nix W., Schofield I. Amplitude, area and duration of the compound muscle action potential change in different ways over the length of the ulnar nerve. Clin Neurophysiol 2006, 117:2085-2092.
78. Johnsen B., Fuglsang-Frederiksen A., Vingtoft S., Fawcett P., Liguori R., Nix W., et al. Differences in the handling of the EMG examination at seven European laboratories. Electroencephalogr Clin Neurophysiol 1994, 93:155-158.
79. Johnsen B., Fuglsang-Frederiksen A., Vingtoft S., Fawcett P., Liguori R., Nix W., et al. Inter- and intraobserver variation in the interpretation of electromyographic tests. Electroencephalogr Clin Neurophysiol 1995, 97:432-443.
80. Kalita J., Misra U.K., Das M. Neurophysiological criteria in the diagnosis of different clinical types of Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry 2008, 79:289-293.
81. Kendall R., Werner R.A. Interrater reliability of the needle examination in lumbosacral radiculopathy. Muscle Nerve 2006, 34:238-241.
82. Kitchener H.C. Clinical practice guidelines: loss of clinical freedom or a coming of age?. Int J Gynecol Cancer 2002, 12:332-336.
83. Knopman D.S., DeKosky S.T., Cummings J.L., Chui H., Corey-Bloom J., Relkin N., et al. Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001, 56:1143-1153.
84. Koski C.L., Baumgarten M., Magder L.S., Barohn R.J., Goldstein J., Graves M., et al. Derivation and validation of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy. J Neurol Sci 2009, 277:1-8.
85. Kothari M.J., Blakeslee M.A., Reichwein R., Simmons Z., Logigian E.L. Electrodiagnostic studies: are they useful in clinical practice?. Arch Phys Med Rehabil 1998, 79:1510-1511.
86. Kothari M.J., Preston D.C., Plotkin G.M., Venkatesh S., Shefner J.M., Logigian E.L. Electromyography: do the diagnostic ends justify the means?. Arch Phys Med Rehabil 1995, 76:947-949.
87. Krarup C., Trojaborg W. Sensory pathophysiology in chronic acquired demyelinating neuropathy. Brain 1996, 119:257-270.
88. Lambert E.H. Electromyography in amyotrophic lateral sclerosis. Motor neuron diseases 1969, 135-153. Grune and Stratton, New York. F.H.K.L. Norris (Ed.).
89. Laughlin R.S., Dyck P.J., Melton L.J., Leibson C., Ransom J., Dyck P.J. Incidence and prevalence of CIDP and the association of diabetes mellitus. Neurology 2009, 73:39-45.
90. Lewis R.A., Sumner A.J., Brown M.J., Asbury A.K. Multifocal demyelinating neuropathy with persistent conduction block. Neurology 1982, 32:958-964.
91. Logigian E.L., Kelly J.J., Adelman L.S. Nerve conduction and biopsy correlation in over 100 consecutive patients with suspected polyneuropathy. Muscle Nerve 1994, 17:1010-1020.
92. Lomas J., Anderson G.M., Domnick-Pierre K., Vayda E., Enkin M.W., Hannah W.J. Do practice guidelines guide practice? The effect of a consensus statement on the practice of physicians. N Engl J Med 1989, 321:1306-1311.
93. Mainz J. Defining and classifying clinical indicators for quality improvement. Int J Qual Health Care 2003, 15:523-530.
94. Marciniak C., Armon C., Wilson J., Miller R. Practice parameter: utility of electrodiagnostic techniques in evaluating patients with suspected peroneal neuropathy: an evidence-based review. Muscle Nerve 2005, 31:520-527.
95. McCombe P.A., Pollard J.D., McLeod J.G. Chronic inflammatory demyelinating polyradiculoneuropathy. A clinical and electrophysiological study of 92 cases. Brain 1987, 110(Pt 6):1617-1630.
96. Meulstee J., Van der Meche F.G. Electrodiagnostic criteria for polyneuropathy and demyelination: application in 135 patients with Guillain-Barre syndrome. Dutch Guillain-Barre Study Group. J Neurol Neurosurg Psychiatry 1995, 59:482-486.
97. Nardin R.A., Rutkove S.B., Raynor E.M. Diagnostic accuracy of electrodiagnostic testing in the evaluation of weakness. Muscle Nerve 2002, 26:201-205.
98. NHS working for patients. Working for patients. NHS white paper. New diagnosis - new prescription. Health Serv J 1989;99:134-7.
99. Nicolas G., Maisonobe T., Le Forestier N., Leger J.M., Bouche P. Proposed revised electrophysiological criteria for chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 2002, 25:26-30.
100. Nobile-Orazio E., Cappellari A., Meucci N., Carpo M., Terenghi F., Bersano A., et al. Multifocal motor neuropathy: clinical and immunological features and response to IVIg in relation to the presence and degree of motor conduction block. J Neurol Neurosurg Psychiatry 2002, 72:761-766.
101. Olney R.K. Guidelines in electrodiagnostic medicine. Consensus criteria for the diagnosis of partial conduction block. Muscle Nerve Suppl 1999, 8:S225-S229.
102. Olney R.K., Lewis R.A., Putnam T.D., Campellone J.V. Consensus criteria for the diagnosis of multifocal motor neuropathy. Muscle Nerve 2003, 27:117-121.
103. Palmer R.H., Lawthers A.G. Promoting ambulatory care quality. QA Rev 1991, 3:1-8.
104. Patel A.T., Gaines K., Malamut R., Park T.A., Toro D.R., Holland N. Usefulness of electrodiagnostic techniques in the evaluation of suspected tarsal tunnel syndrome: an evidence-based review. Muscle Nerve 2005, 32:236-240.
105. Perry D.I., Tarulli A.W., Nardin R.A., Rutkove S.B., Gautam S., Narayanaswami P. Clinical utility of electrodiagnostic studies in the inpatient setting. Muscle Nerve 2009, 40:195-199.
106. Pugdahl K., Fuglsang-Frederiksen A., de Carvalho M., Johnsen B., Fawcett P.R., Labarre-Vila A., et al. Generalised sensory system abnormalities in amyotrophic lateral sclerosis: a European multicentre study. J Neurol Neurosurg Psychiatry 2007, 78:746-749.
107. Pugdahl K., Fuglsang-Frederiksen A., Johnsen B., de Carvalho M., Fawcett P.R., Labarre-Vila A., et al. A prospective multicentre study on sural nerve action potentials in ALS. Clin Neurophysiol 2008, 119:1106-1110.
108. Pugdahl K, Fuglsang-Frederiksen A, Johnsen B, Tankisi H, de Carvalho M, Fawcett PR, et al. Variation in the neurophysiological examination of Amyotrophic Lateral Sclerosis in Europe. Amyotroph Lateral Scler Other Motor Neuron Disord, in press.
109. Pugdahl K., Tankisi H., Fuglsang-Frederiksen A., Johnsen B., de Carvalho M., Fawcett P.R., et al. Influence of medical audit on electrodiagnostic evaluation of polyneuropathy. A multicentre study. Clin Neurophysiol 2005, 116:49-55.
110. Rajabally Y.A., Narasimhan M. The value of sensory electrophysiology in chronic inflammatory demyelinating polyneuropathy. Clin Neurophysiol 2007, 118:1999-2004.
111. Robinson L.R., Micklesen P.J., Wang L. Strategies for analyzing nerve conduction data: superiority of a summary index over single tests. Muscle Nerve 1998, 21:1166-1171.
112. Robinson L.R., Micklesen P.J., Wang L. Optimizing the number of tests for carpal tunnel syndrome. Muscle Nerve 2000, 23:1880-1882.
113. Rosenberg N.R., Portegies P., de Visser M., Vermeulen M. Diagnostic investigation of patients with chronic polyneuropathy: evaluation of a clinical guideline. J Neurol Neurosurg Psychiatry 2001, 71:205-209.
114. Rosenfalck A., Rosenfalck P. Electromyography-sensory and motor conduction. Findings in normal subjects 1975, Rigshospitalet, Copenhagen.
115. Ross M.A., Miller R.G., Berchert L., Parry G., Barohn R.J., Armon C., et al. Toward earlier diagnosis of amyotrophic lateral sclerosis: revised criteria. rhCNTF ALS Study Group. Neurology 1998, 50:768-772.
116. Saperstein D.S., Katz J.S., Amato A.A., Barohn R.J. Clinical spectrum of chronic acquired demyelinating polyneuropathies. Muscle Nerve 2001, 24:311-324.
117. Smidt N., Rutjes A.W., van der Windt D.A., Ostelo R.W., Bossuyt P.M., Reitsma J.B., et al. The quality of diagnostic accuracy studies since the STARD statement: has it improved?. Neurology 2006, 67:792-797.
118. So Y.T. The value of electromyography: toward an evidence-based use of electrodiagnostic testing. Muscle Nerve 2009, 40:171-172.
119. Stanton M., Pannoni V., Lewis R.A., Logigian E.L., Naguib D., Shy M.E., et al. Dispersion of compound muscle action potential in hereditary neuropathies and chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 2006, 34:417-422.
120. Storm S., Beaver S.K., Giardino N., Kliot M., Franklin G.M., Jarvik J.G., et al. Compliance with electrodiagnostic guidelines for patients undergoing carpal tunnel release. Arch Phys Med Rehabil 2005, 86:8-11.
121. Sumner A.J. Consensus criteria for the diagnosis of partial conduction block and multifocal motor neuropathy. Physiology of ALS and related diseases 1997, 221-227. Elsevier, Amsterdam. J. Kimura, R. Kaji (Eds.).
122. Tankisi H., Johnsen B., Fuglsang-Frederiksen A., de Carvalho M., Fawcett P.R., Labarre-Vila A., et al. Variation in the classification of polyneuropathies among European physicians. Clin Neurophysiol 2003, 114:496-503.
123. Tankisi H., Pugdahl K., Fuglsang-Frederiksen A., Johnsen B., de Carvalho M., Fawcett P.R., et al. Influence of peer review medical audit on pathophysiological interpretation of nerve conduction studies in polyneuropathies. Clin Neurophysiol 2006, 117:979-983.
124. Tankisi H., Pugdahl K., Fuglsang-Frederiksen A., Johnsen B., de Carvalho M., Fawcett P.R., et al. Pathophysiology inferred from electrodiagnostic nerve tests and classification of polyneuropathies. Suggested guidelines. Clin Neurophysiol 2005, 116:1571-1580.
125. Tankisi H., Pugdahl K., Johnsen B., Fuglsang-Frederiksen A. Correlations of nerve conduction measures in axonal and demyelinating polyneuropathies. Clin Neurophysiol 2007, 118:2383-2392.
126. Thaisetthawatkul P., Logigian E.L., Herrmann D.N. Dispersion of the distal compound muscle action potential as a diagnostic criterion for chronic inflammatory demyelinating polyneuropathy. Neurology 2002, 59:1526-1532.
127. The Italian Guillain-Barre Study Group. The prognosis and main prognostic indicators of Guillain-Barre syndrome. A multicentre prospective study of 297 patients. The Italian Guillain-Barre Study Group. Brain 1996;119(Pt 6):2053-61.
128. Traynor B.J., Codd M.B., Corr B., Forde C., Frost E., Hardiman O.M. Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria: a population-based study. Arch Neurol 2000, 57:1171-1176.
129. Trojaborg W. Sensory nerve conduction. Near nerve recording. Methods Clin Neurophysiol 1992, 3:17-40.
130. Uncini A., Di M.A., Sabatelli M., Magi S., Tonali P., Gambi D. Sensitivity and specificity of diagnostic criteria for conduction block in chronic inflammatory demyelinating polyneuropathy. Electroencephalogr Clin Neurophysiol 1993, 89:161-169.
131. Van den Bergh P.Y., Pieret F. Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 2004, 29:565-574.
132. Van der Meché F.G., Van Doorn P.A., Meulstee J., Jennekens F.G. Diagnostic and classification criteria for the Guillain-Barre syndrome. Eur Neurol 2001, 45:133-139.
133. Veloso M., Vingtoft S., Carvalho M., Fawcett P., Fuglsang-Frederiksen A., Johnsen B., et al. Quality assurance in clinical neurophysiology: the ESTEEM project example. Stud Health Technol Inform 1995, 16:125-133.
134. Vingtoft S., Fuglsang-Frederiksen A., Ronager J., Petrera J., Stigsby B., Willison R.G., et al. KANDID - an EMG decision support system - evaluated in a European multicenter trial. Muscle Nerve 1993, 16:520-529.
135. Vingtoft S., Johnsen B., Fuglsang-Frederiksen A., Veloso M., Barahona P., Vila A., et al. ESTEEM: a European telematic project for quality assurance within clinical neurophysiology. Medinfo 1995, 8(Pt 2):1047-1051.
136. Vrancken A.F., Kalmijn S., Buskens E., Franssen H., Vermeulen M., Wokke J.H., et al. Feasibility and cost efficiency of a diagnostic guideline for chronic polyneuropathy: a prospective implementation study. J Neurol Neurosurg Psychiatry 2006, 77:397-401.
137. Westert G.P., Groenewegen P.P. Medical practice variations: changing the theoretical approach. Scand J Public Health 1999, 27:173-180.
138. Wilbourn A.J. Clinical neurophysiology in the diagnosis of amyotrophic lateral sclerosis: the Lambert and the El Escorial criteria. J Neurol Sci 1998, 160(Suppl. 1):S25-S29.
139. Willison H.J., Winer J.B. Clinical evaluation and investigation of neuropathy. J Neurol Neurosurg Psychiatry 2003, ii3-ii8.